Caas Capital Management LP Apellis Pharmaceuticals, Inc. Put Options Transaction History
Caas Capital Management LP
- $895 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding APLS
# of Institutions
295Shares Held
124MCall Options Held
921KPut Options Held
761K-
Wellington Management Group LLP Boston, MA12.3MShares$219 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.2MShares$217 Million4.32% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$211 Million20.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$180 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.63MShares$171 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $1.95B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...